Anbio Biotechnology
NNNN
$6.61
$0.040.61%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.31M | 10.31M | 9.69M | 9.69M | 10.56M |
| Total Receivables | 4.62M | 4.62M | 1.89M | 1.89M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.84M | 3.84M | 4.17M | 4.17M | 4.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.50K | 5.50K | 3.30K | 3.30K | 4.90K |
| Total Current Assets | 18.77M | 18.77M | 15.75M | 15.75M | 15.15M |
|
|
|||||
| Total Current Assets | 18.77M | 18.77M | 15.75M | 15.75M | 15.15M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | 3.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 177.00K | 177.00K | 62.10K | 62.10K | 276.80K |
| Total Assets | 18.94M | 18.94M | 15.81M | 15.81M | 15.43M |
|
|
|||||
| Total Accounts Payable | 479.00K | 479.00K | 827.20K | 827.20K | 1.31M |
| Total Accrued Expenses | 17.30K | 17.30K | 131.00K | 131.00K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 31.40K | 31.40K | 34.90K | 34.90K | 33.80K |
| Total Other Current Liabilities | 31.40K | 31.40K | 34.90K | 34.90K | 33.80K |
| Total Current Liabilities | 527.80K | 527.80K | 993.10K | 993.10K | 1.34M |
|
|
|||||
| Total Current Liabilities | 527.80K | 527.80K | 993.10K | 993.10K | 1.34M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 527.80K | 527.80K | 993.10K | 993.10K | 1.34M |
|
|
|||||
| Common Stock & APIC | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Retained Earnings | 18.40M | 18.40M | 14.80M | 14.80M | 14.07M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 18.42M | 18.42M | 14.82M | 14.82M | 14.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.42M | 18.42M | 14.82M | 14.82M | 14.09M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.42M | 18.42M | 14.82M | 14.82M | 14.09M |
|
|
|||||